BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30537507)

  • 21. The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.
    Gaynon PS; Lustig RH
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):1-12. PubMed ID: 7743230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance.
    Bonapace L; Bornhauser BC; Schmitz M; Cario G; Ziegler U; Niggli FK; Schäfer BW; Schrappe M; Stanulla M; Bourquin JP
    J Clin Invest; 2010 Apr; 120(4):1310-23. PubMed ID: 20200450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid receptors in human leukemias and related diseases.
    Thompson EB; Smith JR; Bourgeois S; Harmon JM
    Klin Wochenschr; 1985 Aug; 63(15):689-98. PubMed ID: 2413243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
    Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
    J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.
    Jiang N; Koh GS; Lim JY; Kham SK; Ariffin H; Chew FT; Yeoh AE
    Exp Hematol; 2011 Mar; 39(3):321-9, 329.e1-3. PubMed ID: 21130142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
    Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
    Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
    Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
    Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
    Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
    Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A semantics-oriented computational approach to investigate microRNA regulation on glucocorticoid resistance in pediatric acute lymphoblastic leukemia.
    Chen H; Zhang D; Zhang G; Li X; Liang Y; Kasukurthi MV; Li S; Borchert GM; Huang J
    BMC Med Inform Decis Mak; 2018 Jul; 18(Suppl 2):57. PubMed ID: 30066657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
    Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
    Leukemia; 2004 Mar; 18(3):530-7. PubMed ID: 14724649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
    Paugh SW; Bonten EJ; Savic D; Ramsey LB; Thierfelder WE; Gurung P; Malireddi RK; Actis M; Mayasundari A; Min J; Coss DR; Laudermilk LT; Panetta JC; McCorkle JR; Fan Y; Crews KR; Stocco G; Wilkinson MR; Ferreira AM; Cheng C; Yang W; Karol SE; Fernandez CA; Diouf B; Smith C; Hicks JK; Zanut A; Giordanengo A; Crona D; Bianchi JJ; Holmfeldt L; Mullighan CG; den Boer ML; Pieters R; Jeha S; Dunwell TL; Latif F; Bhojwani D; Carroll WL; Pui CH; Myers RM; Guy RK; Kanneganti TD; Relling MV; Evans WE
    Nat Genet; 2015 Jun; 47(6):607-14. PubMed ID: 25938942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the effect of 3 glucocorticoid receptor gene polymorphisms on risk of relapse in 100 Iranian children with acute lymphoblastic leukemia: a case-control study.
    Namazi S; Zareifar S; Monabati A; Ansari S; Karimzadeh I
    Clin Ther; 2011 Mar; 33(3):280-90. PubMed ID: 21497906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells.
    Lu J; Quearry B; Harada H
    FEBS Lett; 2006 Jun; 580(14):3539-44. PubMed ID: 16730715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of 11beta-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia.
    Sai S; Nakagawa Y; Sakaguchi K; Okada S; Takahashi H; Hongo T; Seckl JR; Chapman KE; Ohzeki T
    Leuk Res; 2009 Dec; 33(12):1696-8. PubMed ID: 19446331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent labeling of rat thymocyte and human lymphoid glucocorticoid receptor.
    Foster CM; Eisen HJ; Bloomfield CD
    Cancer Res; 1983 Nov; 43(11):5273-7. PubMed ID: 6577947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of glucocorticoid on the expression of Puma in acute lymphoblastic leukemia].
    Xu B; Wang BJ; Li AM; Lock R
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):151-4. PubMed ID: 16613713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
    Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
    Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticosteroids induce DNA fragmentation in human lymphoid leukemia cells.
    Distelhorst CW
    Blood; 1988 Oct; 72(4):1305-9. PubMed ID: 3262387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.